影像组学在预测癌症基因突变中的应用
本文简要总结影像基因组学在预测脑、肺、结直肠、乳腺和肾脏肿瘤基因突变中的当前作用。影像基因组学旨在将影像特征与基因表达模式、基因突变及其他基因组相关特征相关联;由于医学影像的无创性,该领域快速发展,可能作为基因检测的替代工具。分子靶向治疗在个体化癌症精准治疗中的作用日益重要,但基因检测仍然昂贵、有创且耗时,并非所有患者都可获得。
要点
- 影像基因组学旨在将影像特征与基因表达模式、基因突变及其他基因组相关特征相关联。
- 由于医学影像的无创性,影像基因组学可能作为基因检测的替代工具。
- 影像基因组学领域前景广阔,但仍有若干局限性需要克服。
核心结论
- 影像基因组学可能提供准确的影像生物标志物,作为基因检测的替代工具。
研究设计与样本
- 本文为综述,简要总结影像基因组学在预测脑、肺、结直肠、乳腺和肾脏肿瘤基因突变中的当前作用,原文未报告检索范围与纳入文献数量。
诊断标准与关键数值
- 影像基因组学旨在将影像特征与基因表达模式、基因突变及其他基因组相关特征相关联,原文未报告具体诊断标准与数值。
临床应用与阅片要点
- 由于医学影像的无创性,影像基因组学领域快速发展,可能作为基因检测的替代工具。
局限性
- 原文指出影像基因组学领域前景广阔,但仍有若干局限性需要克服,原文未逐条列出具体局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
With the development of genome sequencing, the role of molecular targeted therapy in cancer is becoming increasingly important. However, genetic testing remains expensive, invasive, and time-consuming, and thus unavailable for all patients. Radiogenomics aims to correlate imaging characteristics with gene expression patterns, gene mutations, and other genome-related characteristics. Due to the noninvasive nature of medical imaging, the field of radiogenomics is rapidly developing and may serve as a substitute tool for genetic testing. In this article, we briefly summarise the current role of radiogenomics in predicting gene mutations in brain, lung, colorectal, breast, and kidney tumours. KEY POINTS: • The role of molecular targeted therapy in individual cancer-precision therapy is becoming increasingly important with the development of genetic testing. • Radiogenomics may provide accurate imaging biomarkers as a substitute for genetic testing. • While the field of radiogenomics holds great promise, there are still a number of limitations that need to be overcome.
引用
- Qi, Zhao, Han, et al. The application of radiomics in predicting gene mutations in cancer. Eur Radiol. 2022. PMID: 35048135. doi:10.1007/s00330-021-08520-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。